From: Serial measurements of serum PDGF-AA, PDGF-BB, FGF2, and VEGF in multiresistant ovarian cancer patients treated with bevacizumab
PDGF-AA
PDGF-BB
FGF2
r = 0.80 (p < 10-5)
r = 0.42 (p < 10-5)
r = 0.32 (p = 0.003)
VEGF
r = 0.50 (p < 10-5)
r = 0.53 (p < 10-5)
r = 0.25 (p = 0.02)